Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
Statistics in Medicine · 2024
DOI: 10.1002/sim.10115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Edward L Korn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biometric Research Program, National Cancer Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design, Endpoint Determination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
When designing a randomized clinical trial to compare two treatments, the sample size required to have desired power with a specified type 1 error depends on the hypothesis testing procedure. With a binary endpoint (e.g., response), the trial results can be displayed in a 2 × 2 table. If one does the analysis conditional on the number of positive responses, then using Fisher's exact test has an actual type 1 error less than or equal to the specified nominal type 1 error. Alternatively, one can use one of many unconditional “exact” tests that also preserve the type 1 error and are less conservative than Fisher's exact test. In particular, the unconditional test of Boschloo is always at least as powerful as Fisher's exact test, leading to smaller required sample sizes for clinical trials. However, many statisticians have argued over the years that the conditional analysis with Fisher's exact test is the only appropriate procedure. Since having smaller clinical trials is an extremely important consideration, we review the general arguments given for the conditional analysis of a 2 × 2 table in the context of a randomized clinical trial. We find the arguments not relevant in this context, or, if relevant, not completely convincing, suggesting the sample‐size advantage of the unconditional tests should lead to their recommended use. We also briefly suggest that since designers of clinical trials practically always have target null and alternative response rates, there is the possibility of using this information to improve the power of the unconditional tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biometric Research Program, National Cancer Institute, Bethesda, Maryland, USA.
ORCID-Profile: Edward L Korn
Zitieren
APA
Korn, E. L., & Freidlin, B. (2024). Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table. Statistics in Medicine. https://doi.org/10.1002/sim.10115
Vancouver
Korn EL, Freidlin B. Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table. Statistics in Medicine. 2024. doi:10.1002/sim.10115
BibTeX
@article{Korn2024,
author = {Korn, Edward L and Freidlin, Boris},
title = {Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10115}
}
EUVIMED